Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Novel agents in invasive urothelial cancer.

Clinical advances in hematology & oncology : H&O - 1 Aug 2012

Balar Arjun V, Milowsky Matthew I

Abstract excerpt

Invasive urothelial cancer is an aggressive, biologically heterogeneous disease. Most patients present with non-muscle invasive bladder cancer involving the epithelium as exophytic tumors, in situ carcinoma, or minimally invasive disease involving the lamina propria. Such patients are typically managed with complete transurethral resection with or without intravesical therapy. Muscle invasive urothelial cancer,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Carcinoma in Situ
Share to Folic Acid Antagonists
Share to Mucous Membrane

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to PTEN Phosphohydrolase

Share to Receptors, Vascular Endothelial Growth Factor

Share to Retinoblastoma Protein

Share to Taxoids

Share to Urothelium

Source

Identifiers

PMID: 23073049

Genes

PTEN

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026. Manifest publication-graph-cohort-2026-09-05.1.

Source receipt: pubmed, retrieved 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Novel agents in invasive urothelial cancer.PMID 23073049Read ↗

Beyond conventional chemotherapy: Emerging molecular targeted and immunotherapy strategies in urothelial carcinoma.Semantic proximity Read ↗

Management of advanced bladder cancer in the era of targeted therapies.Semantic proximity Read ↗

Emerging therapeutic targets in bladder cancer.Semantic proximity Read ↗

New and promising strategies in the management of bladder cancer.Semantic proximity Read ↗

Molecular targets and targeted therapies in bladder cancer managementSemantic proximity Read ↗

Molecular profiling of infiltrating urothelial carcinoma of bladder and nonbladder origin.Semantic proximity Read ↗

Molecular aspects of upper tract urothelial carcinoma.Semantic proximity Read ↗

Molecularly Targeted Therapy towards Genetic Alterations in Advanced Bladder CancerSemantic proximity Read ↗

Cytotoxic and DNA-targeted therapy in urothelial cancer: have we squeezed the lemon enough?Semantic proximity Read ↗

Latest progress in molecular biology and treatment in genitourinary tumours.Semantic proximity Read ↗

Molecular Pathways in Invasive Bladder Cancer: New Insights Into Mechanisms, Progression, and Target IdentificationSemantic proximity Read ↗

New Approaches to Targeting Epigenetic Regulation in Bladder CancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.